Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM

Fig. 3

CB2R distribution among DM skin and DM PBMCs via flow cytometry. DM and HC peripheral blood PBMCs and skin cells isolated and stained via flow cytometry. a Percentage of CB2R expression in CD4+ T cells, CD11c+ mDCs, and CD123+ pDCs compared between DM peripheral blood and skin. b CB2R expression in skin and peripheral blood samples of a single patient shown with respect to CD4+ T cells, CD11c+ mDCs, and CD123+ pDCs. Graph shows the median. ***p<0.001. DM, dermatomyositis; HC, healthy control; mDC, myeloid dendritic cells; PBMC, peripheral blood mononuclear cell; pDC, plasmacytoid dendritic cell

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us